论文信息 - Alopecia Associated with HMG-CoA Reductase Inhibitor; “Delayed, Recurrent” SIADH and SSRIs; Serious Adverse Effects with Acetazolamide; Tetany Associated with Proton Pump Inhibitor

Alopecia Associated with HMG-CoA Reductase Inhibitor; “Delayed, Recurrent” SIADH and SSRIs; Serious Adverse Effects with Acetazolamide; Tetany Associated with Proton Pump Inhibitor

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), to discuss methods of prevention, and to promote reporting of ADRs to the FDA's medWatch program (800-FDA-1088). If you have reported an interesting preventable ADR to medWatch, please consider sharing the account with our readers.

J. Shuster

[1] T. Kaptchuk,et al. Varieties of Healing , 2002 .

[2] J. Tayek,et al. Tetany secondary to the use of a proton-pump inhibitor. , 2002, Annals of internal medicine.

[3] E. Elinav,et al. Recurrent life-threatening acidosis induced by acetazolamide in a patient with diabetic type IV renal tubular acidosis. , 2002, Annals of emergency medicine.

[4] A. Segal. Alopecia associated with atorvastatin. , 2002, The American journal of medicine.

[5] Z. Arinzon,et al. Delayed Recurrent SIADH Associated with SSRIs , 2002, The Annals of pharmacotherapy.

[6] C. Orzincolo,et al. Anaphylactic shock and acute pulmonary edema after a single oral dose of acetazolamide. , 2002, The American journal of emergency medicine.